Nuvectis Pharma to present NXP900 data at 2026 cancer research meeting

Go back to Nuvectis Pharma to present NXP900 data at 2026 cancer research meeting
(NASDAQ: NVCT) Delayed: 19.63 --0 (-0%)
Previous Close $19.63    52 Week High
Open $19.63    52 Week Low
Day High $19.63    P/E N/A 
Day Low $19.63    EPS
Volume 92